Latest Medtech News
Tenon Medical, Inc., a company focused on care for patients with certain sacro-pelvic disorders, has entered into a securities purchase agreement with an institutional investor for a private placement expected to raise approximately $3 million in gross proceeds. The offering, announced by placement agent WallachBeth Capital LLC on August 28, covers 597,610 shares of common stock (or pre-funded warrants in lieu of shares) alongside warrants for up to 1,058,517 additional shares, priced at a combined effective offering price of $5.02 per share and accompanying warrant. The warrants carry a five-year term and are immediately exercisable at $5.02 per share.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.
The offering is expected to close on or about August 31, 2026, subject to customary closing conditions, with WallachBeth Capital acting as sole placement agent. The press release does not specify an intended use of proceeds.
For Tenon Medical, best known for its Catamaran SI Joint Fusion System, the raise adds a modest amount of near-term capital, though the structure, priced equity paired with long-dated warrants, is a common approach for small-cap medical device companies managing dilution while extending their cash runway. For the broader MedTech space, it's a reminder that access to capital remains uneven: while later-stage and larger companies continue to draw sizable venture and growth rounds, smaller public device companies are still turning to smaller, warrant-heavy private placements to fund operations.
